What health condition does Gaten Matarazzo have?
Gaten Matarazzo has a rare genetic disorder called cleidocranial dysplasia (CCD). CCD affects bone and tooth development because of variants in the RUNX2 gene. It is not contagious, not tied to lifestyle, and is present from conception. This article explains what CCD is, how it relates to Matarazzo, common signs, management, and reliable ways to learn more. The information below is intended to clarify the condition in a factual, practical way.
Overview of cleidocranial dysplasia
Cleidocranial dysplasia is a non-life-threatening genetic condition that primarily impacts skeletal development. It can cause delayed closure of skull sutures, underdeveloped or absent collarbones, dental abnormalities, and differences in the structure of the face and long bones. People with CCD may have loose joints, short stature, and distinctive facial features. The condition varies widely, even within the same family, which means experiences differ from person to person. Most cases are not inherited and occur due to new variants in RUNX2.
Gaten Matarazzo’s diagnosis and public discussion
Gaten Matarazzo first discussed his CCD diagnosis with the public around 2017, notably during a 2017 TV interview with People. He has since used his platform to explain the condition in everyday terms, clarify misconceptions, and show how it fits into his work and personal life. Matarazzo has emphasized that CCD does not define him, but understanding it helps others recognize how he manages certain physical and medical aspects. His openness has contributed to broader awareness of rare genetic conditions.
Key facts at a glance
| Attribute | Verified Detail | Source Type |
|---|---|---|
| Condition | Cleidocranial dysplasia (CCD) | Medical consensus, clinical literature |
| Cause | RUNX2 gene variants | Scientific research, genetics studies |
| Inheritance | Autosomal dominant; many cases are de novo | Genetics references, peer-reviewed sources |
| Onset | Present from conception; features evident in childhood | Clinical guidelines, medical reviews |
| Public disclosure | Shared in multiple interviews, including People (2017) and later updates | Published interviews, reputable media |
| General prognosis | Non-life-threatening; variable expression; manageable care | Clinical literature, patient advocacy groups |
How CCD typically presents and is evaluated
People with CCD may experience a wide range of physical features and functional considerations. Common signs include delayed closure of skull sutures, open fontanelles, underdeveloped or absent clavicles, dental crowding or extra teeth, and shorter stature. Some individuals have hearing loss due to ear structure differences. Diagnosis often involves a clinical exam, family history, imaging (such as X-rays), and genetic testing for RUNX2 variants. Because CCD is a genetic skeletal condition, care is often coordinated among multiple specialists.
Signs and features commonly associated with CCD
- Underdeveloped or absent collarbones (clavicles)
- Delayed closure of skull sutures and fontanelles
- Dental anomalies, such as extra teeth or crowding
- Distinctive facial features, including wide-set eyes
- Short stature relative to peers
- Loose joints and flexible joints
- Mild to moderate hearing loss in some individuals
Managing cleidocranial dysplasia in daily life
Management of CCD is individualized and often involves regular medical follow-up. Dental care is commonly a central part of treatment, including orthodontics and surgical options for impacted teeth. Physical and occupational therapy may help with joint stability and movement. In some cases, surgery is considered for severe skeletal issues or to address hearing loss. Because CCD is not progressive, many aspects of care focus on optimizing function and comfort rather than curing the condition. People with CCD usually have a normal lifespan when supported by appropriate care.
Common aspects of long-term management
- Routine dental evaluations and orthodontic or surgical dental care
- Physical or occupational therapy for joint support
- Monitoring for hearing loss with audiology assessments
- Imaging and specialist exams for skeletal development
- Coordination among geneticists, dentists, and other clinicians
Genetics, inheritance, and family considerations
CCD follows an autosomal dominant pattern, meaning one copy of a changed RUNX2 gene in each cell is sufficient to cause the condition. Many people with CCD, including Matarazzo, have a de novo variant, which means the change occurred spontaneously and was not inherited from a parent. Genetic counseling is available for individuals and families who want clearer information about recurrence risks, family planning, and testing options. Understanding inheritance can help relatives make informed decisions about genetic evaluation.
Inheritance patterns simplified
- Autosomal dominant: one changed copy of a gene can cause the condition
- De novo changes are common in CCD and not due to parental behavior
- Each child of a parent with CCD has about a 50% chance of inheriting the variant
- Genetic counseling can clarify personal and family-specific risks
Reliable resources and support options
For people who want more information, reputable sources include patient advocacy organizations and clinical guidelines. These resources provide summaries of symptoms, management strategies, and the latest research in an accessible way. Connecting with support communities can also offer practical tips and emotional support. Because medical information evolves, it’s best to rely on trusted healthcare providers and recognized organizations rather than unverified online claims.
Places to find reliable information and community support
- Genetic and Rare Diseases Information Center (GARD)
- National Organization for Rare Disorders (NORD)
- CDC genetic conditions resources
- Patient-led communities and advocacy groups focused on CCD
- Specialist genetics clinics and academic medical centers